Govt Job: For Senior Research Associate at | Salary Rs. 60,000 pm

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Senior Research Associate

Project title : “Exploring the content validity of the EQ-5D across cultures using standard quantitative methods”

Department : Department of Community Medicine & School of Public Health, PGIMER, Chandigarh

Qualification
Essential :

– Master’s degree in Public Health / Health Management / Hospital Administration / Pharmacy / MD Community Medicine with 6 month teaching or research experience.

Desirable :
– Good analytic and scientific writing skills.
– Experience of writing project reports, publication in peer review journals.

Duration : 5 months
Emolument s per months (in Rs.) : 60,000/-

How to Apply : Interested candidates should submit their curriculum vitae with supporting documents to Mr Anil Kumar, Room No-004 Department of Community Medicine and School of Public Health PGIMER, Chandigarh or may also apply through online mode by sending email to recruitment.htapgi@gmail.com by 12th May, at 12.00 PM 2022.

No application by any means will be received or entertained after last date. You will be informed in case there is any change in schedule/mode of recruitment process.

Date of Interview : 14th May 2022 at 09.00 AM.

Venue : Committee Room, Community Medicine and School of Public Health, PGIMER, Chandigarh.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March